Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

ClinicalTrials.gov ID: NCT01695343

Public ClinicalTrials.gov record NCT01695343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa

Study identification

NCT ID
NCT01695343
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Humanigen, Inc.
Industry
Enrollment
182 participants

Conditions and interventions

Interventions

  • KB001-A Biological
  • Placebo Comparator Drug

Biological · Drug

Eligibility (public fields only)

Age range
12 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2012
Primary completion
Oct 31, 2014
Completion
Nov 30, 2014
Last update posted
Jan 13, 2015

2012 – 2014

United States locations

U.S. sites
58
U.S. states
29
U.S. cities
55
Facility City State ZIP Site status
Not listed Mobile Alabama 36608
Not listed Phoenix Arizona 85016
Not listed Tucson Arizona 85724
Not listed Little Rock Arkansas 72205
Not listed Long Beach California 90806
Not listed Oakland California 94611
Not listed Orange California 92868
Not listed Stanford California 94304
Not listed Aurora Colorado 80045
Not listed Gainesville Florida 32610
Not listed Miami Florida 33136
Not listed Orlando Florida 32806
Not listed Tampa Florida 33606
Not listed Atlanta Georgia 30322
Not listed Boise Idaho 83712
Not listed Glenview Illinois 60025
Not listed Indianapolis Indiana 46202
Not listed Iowa City Iowa 52242
Not listed Lexington Kentucky 40536
Not listed Louisville Kentucky 40202
Not listed Portland Maine 04102
Not listed Boston Massachusetts 02115
Not listed Worchester Massachusetts 10655
Not listed Detriot Michigan 48201
Not listed Grand Rapids Michigan 49503
Not listed Minneapolis Minnesota 55455
Not listed Kansas City Missouri 64108
Not listed St Louis Missouri 63104
Not listed St Louis Missouri 63110
Not listed Hanover New Hampshire 03756
Not listed Manchester New Hampshire 03756
Not listed Albuquerque New Mexico 87131
Not listed Albany New York 12208
Not listed Hawthorne New York 10532
Not listed New Hyde Park New York 11040
Not listed New York New York 10032
Not listed Cincinnati Ohio 45229
Not listed Cincinnati Ohio 45267
Not listed Cleveland Ohio 44106
Not listed Columbus Ohio 43205
Not listed Dayton Ohio 45404
Not listed Toledo Ohio 43606
Not listed Oklahoma City Oklahoma 73104
Not listed Hershey Pennsylvania 17033
Not listed Philadelphia Pennsylvania 19102
Not listed Philadelphia Pennsylvania 19104
Not listed Pittsburgh Pennsylvania 15224
Not listed Charleston South Carolina 29425
Not listed Knoxville Tennessee 37916
Not listed Memphis Tennessee 38105
Not listed Nashville Tennessee 37232
Not listed Austin Texas 78723
Not listed Dallas Texas 75390
Not listed San Antonio Texas 78212
Not listed Colchester Vermont 05446
Not listed Richmond Virginia 23219
Not listed Madison Wisconsin 53792
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01695343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01695343 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →